News | August 05, 2011

Gold Nanoparticles Could Help Deliver One-Two Punch To Cancer, Suggests Early Research

August 5, 2011 – Microscopic gold particles could multiply the effectiveness of standard cancer radiation therapy by acting as tiny missiles that destroy blood vessels feeding cancerous tumors. Early research about this method, which could shorten cancer treatment and make it more effective, was presented at the 2011 Joint Meeting of the American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP).

The addition of gold nanoparticles to radiation therapy is a new approach to improving cancer treatments. The study presented focuses on the combination of gold nanoparticles and brachytherapy, a type of radiation treatment in which rice-sized low-energy radiation-emitting seeds are implanted near or within cancerous tumors. Like other forms of radiation therapy, brachytherapy damages the DNA of cancer cells, leading to their death. Supplementing brachytherapy with gold nanoparticles would add a new cancer-killing mechanism that collapses the blood vessels, effectively strangling the tumor, the research suggests.

“The idea is to deliver a one-two punch to the cancer: bombard the tumor with standard radiation therapy while also attacking its blood supply,” said Ross I. Berbeco, Ph.D., lead author of the study and staff physicist at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and assistant professor at Harvard Medical School, Boston. “Although we have also shown that the concept may work for external beam radiation therapy, brachytherapy is particularly attractive for this idea due to the way this low-energy type of radiation interacts with the gold.”

The research suggests that gold nanoparticles may act as a vascular disrupting agent (VDA), cutting off the flow of blood to the tumor by destroying the cells that line tumor-feeding blood vessels. Most VDAs are delivered through chemotherapy, and studies have shown supplementing radiation with VDA chemotherapy may improve cancer treatment. The Brigham and Women’s research suggests that the gold nanoparticles could destroy the blood vessels at the same time radiation therapy is administered.

To test their concept, researchers performed a computer simulation of gold nanoparticles in a tumor blood vessel cell, where brachytherapy seeds had been placed nearby. Results show the gold nanoparticles boost the radiation dose to the blood vessel cells. The researchers next will test the method in live cancer cells.

“We think this is an exciting opportunity for a low-risk, high-reward procedure that could improve cancer care,” said co-author Wilfred F. Ngwa, Ph.D., research fellow at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston.

One million times smaller than the head of a pin, the nanoparticles would be dispersed in a liquid that could be injected into the blood stream. Molecules or proteins attached to the nanoparticles would direct them to target the tumor blood vessel. Gold is an ideal material for this type of therapy because it is relatively non-toxic and its high atomic number boosts the brachytherapy radiation dose.



Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...